Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Identification of a leucine-mediated threshold effect governing macrophage mTOR signalling and cardiovascular risk

Nature Metabolism volume 6, pages 359–377 (2024)Cite this article

Subjects

Abstract

High protein intake is common in western societies and is often promoted as part of a healthy lifestyle; however, amino-acid-mediated mammalian target of rapamycin (mTOR) signalling in macrophages has been implicated in the pathogenesis of ischaemic cardiovascular disease. In a series of clinical studies on male and female participants (NCT03946774 and NCT03994367) that involved graded amounts of protein ingestion together with detailed plasma amino acid analysis and human monocyte/macrophage experiments, we identify leucine as the key activator of mTOR signalling in macrophages. We describe a threshold effect of high protein intake and circulating leucine on monocytes/macrophages wherein only protein in excess of ∼25 g per meal induces mTOR activation and functional effects. By designing specific diets modified in protein and leucine content representative of the intake in the general population, we confirm this threshold effect in mouse models and find ingestion of protein in excess of ∼22% of dietary energy requirements drives atherosclerosis in male mice. These data demonstrate a mechanistic basis for the adverse impact of excessive dietary protein on cardiovascular risk.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Very high protein intake induces mTORC1 activation and inhibition of autophagy in isolated human monocytes.
Fig. 2: High-protein intake induces mTORC1 activation and inhibition of autophagy in isolated human monocytes.
Fig. 3: Plasma amino acid concentration profiles after low, standard, high and very high protein intake.
Fig. 4: Identification of leucine as the most consequential amino acid for mTORC1 activation in HMDMs.
Fig. 5: Leucine-mediated mTORC1 activation and downstream sequela in HMDMs.
Fig. 6: Leucine is the most consequential amino acid for mTORC1 activation in murine monocytes/macrophages in vitro and in vivo.
Fig. 7: Impact of varying dietary protein intake on atherosclerosis in a mouse model.
Fig. 8: Effects of dietary protein and leucine intake on macrophage mTORC1 signalling and atherosclerotic cardiovascular risk.

Similar content being viewed by others

Data availability

All source data used to generate the figures are available as part of the manuscript files and from the corresponding authors upon reasonable request. Source data are provided with this paper.

References

  1. Fan, J. et al. Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine. Pharmacol. Ther. 146, 104–119 (2015).

    Article  CAS  PubMed  Google Scholar 

  2. Debry, G. Dietary Proteins and Atherosclerosis 1st edn https://doi.org/10.1201/9780203009307 (Taylor & Francis, 2003).

  3. Zhang, X. et al. High-protein diets increase cardiovascular risk by activating macrophage mTOR to suppress mitophagy. Nat. Metab. 2, 110–125 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Wolfson, R. L. et al. Sestrin2 is a leucine sensor for the mTORC1 pathway. Science 351, 43–48 (2016).

    Article  ADS  CAS  PubMed  Google Scholar 

  5. Saxton, R. A., Chantranupong, L., Knockenhauer, K. E., Schwartz, T. U. & Sabatini, D. M. Mechanism of arginine sensing by CASTOR1 upstream of mTORC1. Nature 536, 229–233 (2016).

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  6. Goberdhan, D. C. I., Wilson, C. & Harris, A. L. Amino acid sensing by mTORC1: intracellular transporters mark the spot. Cell Metab. 23, 580–589 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (The National Academies Press, 2005).

  8. Bauer, J. et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the prot-age study group. J. Am. Med. Dir. Assoc. 14, 542–559 (2013).

    Article  PubMed  Google Scholar 

  9. Rizzoli, R., Biver, E. & Brennan-Speranza, T. C. Nutritional intake and bone health. Lancet Diabetes Endocrinol. 9, 606–621 (2021).

    Article  CAS  PubMed  Google Scholar 

  10. Berryman, C. E., Lieberman, H. R., Fulgoni, V. L. & Pasiakos, S. M. Protein intake trends and conformity with the dietary reference intakes in the United States: analysis of the National Health and Nutrition Examination Survey, 2001–2014. Am. J. Clin. Nutr. 108, 405–413 (2018).

    Article  PubMed  Google Scholar 

  11. Mangano, K. M. et al. Dietary protein is associated with musculoskeletal health independently of dietary pattern: the Framingham Third Generation Study. Am. J. Clin. Nutr. 105, 714–722 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Anderson, J. J. et al. Adiposity among 132 479 UK Biobank participants; contribution of sugar intake vs other macronutrients. Int. J. Epidemiol. 46, 492–501 (2017).

    ADS  CAS  PubMed  Google Scholar 

  13. Lieberman, H. R., Fulgoni, V. L., Agarwal, S., Pasiakos, S. M. & Berryman, C. E. Protein intake is more stable than carbohydrate or fat intake across various US demographic groups and international populations. Am. J. Clin. Nutr. 112, 180–186 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  14. Millward, D. J. Nutrition and sarcopenia: evidence for an interaction. Proc. Nutr. Soc. 71, 566–575 (2012).

    Article  CAS  PubMed  Google Scholar 

  15. Fabek, H. et al. An examination of contributions of animal- and plant-based dietary patterns on the nutrient quality of diets of adult Canadians. Appl. Physiol. Nutr. Metab. 46, 877–886 (2021).

    Article  CAS  PubMed  Google Scholar 

  16. Chen, Z. et al. Dietary protein intake and all-cause and cause-specific mortality: results from the Rotterdam Study and a meta-analysis of prospective cohort studies. Eur. J. Epidemiol. 35, 411–429 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Aggarwal, A. & Drewnowski, A. Plant- and animal-protein diets in relation to sociodemographic drivers, quality, and cost: fFindings from the Seattle Obesity Study. Am. J. Clin. Nutr. 110, 451–460 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  18. Lin, Y. et al. Plant and animal protein intake and its association with overweight and obesity among the Belgian population. Br. J. Nutr. 105, 1106–1116 (2011).

    Article  CAS  PubMed  Google Scholar 

  19. Van Nielen, M. et al. Dietary protein intake and incidence of type 2 diabetes in Europe: the EPIC-InterAct case-cohort study. Diabetes Care 37, 1854–1862 (2014).

    Article  PubMed  Google Scholar 

  20. Johnston, B. C. et al. Unprocessed red meat and processed meat consumption: dietary guideline recommendations from the nutritional recommendations (NUTRIRECS) consortium. Ann. Intern. Med. 171, 756–764 (2019).

    Article  PubMed  Google Scholar 

  21. Song, M. et al. Association of animal and plant protein intake with all-cause and cause-specific mortality. JAMA Intern. Med. 179, 1509–1518 (2016).

    Google Scholar 

  22. Woollard, K. J. & Geissmann, F. Monocytes in atherosclerosis: subsets and functions. Nat. Rev. Cardiol. 7, 77–86 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  23. Ghattas, A., Griffiths, H. R., Devitt, A., Lip, G. Y. H. & Shantsila, E. Monocytes in coronary artery disease and atherosclerosis: where are we now? J. Am. Coll. Cardiol. 62, 1541–1551 (2013).

    Article  CAS  PubMed  Google Scholar 

  24. Hilgendorf, I., Swirski, F. K. & Robbins, C. S. Monocyte fate in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 35, 272–279 (2015).

    Article  CAS  PubMed  Google Scholar 

  25. Bzowska, M. et al. Oxidized LDLs inhibit TLR-induced IL-10 production by monocytes: a new aspect of pathogen-accelerated atherosclerosis. Inflammation 35, 1567–1584 (2012).

    Article  CAS  PubMed  Google Scholar 

  26. Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. https://doi.org/10.1080/15548627.2020.1797280 (2021).

  27. Van der Vieren, M. et al. A novel leukointegrin, αdβ2, binds preferentially to ICAM-3. Immunity 3, 683–690 (1995).

    Article  PubMed  Google Scholar 

  28. Podolnikova, N. P., Kushchayeva, Y. S., Wu, Y. F., Faust, J. & Ugarova, T. P. The role of integrins αMβ2 (Mac-1, CD11b/CD18) and αDβ2 (CD11d/CD18) in macrophage fusion. Am. J. Pathol. 186, 2105–2116 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Chistiakov, D. A., Killingsworth, M. C., Myasoedova, V. A., Orekhov, A. N. & Bobryshev, Y. V. CD68/macrosialin: not just a histochemical marker. Lab. Investig. 97, 4–13 (2017).

    Article  CAS  PubMed  Google Scholar 

  30. Jewell, J. L. et al. Differential regulation of mTORC1 by leucine and glutamine. Science 347, 194–198 (2015).

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  31. Atherton, P. J., Smith, K., Etheridge, T., Rankin, D. & Rennie, M. J. Distinct anabolic signalling responses to amino acids in C2C12 skeletal muscle cells. Amino Acids 38, 1533–1539 (2010).

    Article  CAS  PubMed  Google Scholar 

  32. Yin, S. et al. Vascular effects of a low-carbohydrate high-protein diet. Proc. Natl Acad. Sci. USA 106, 1–6 (2009).

    Google Scholar 

  33. Solon-Biet, S. M. et al. The ratio of macronutrients, not caloric intake, dictates cardiometabolic health, aging, and longevity in ad libitum-fed mice. Cell Metab. 19, 418–430 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Mu, W. C., Vanhoosier, E., Elks, C. M. & Grant, R. W. Long-term effects of dietary protein and branched-chain amino acids on metabolism and inflammation in mice. Nutrients 10, 918 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  35. Yap, Y. W. et al. Restriction of essential amino acids dictates the systemic metabolic response to dietary protein dilution. Nat. Commun. 11, 2894 (2020).

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  36. Maida, A. et al. Repletion of branched chain amino acids reverses mTORC1 signaling but not improved metabolism during dietary protein dilution. Mol. Metab. 6, 873–881 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Fontana, L. et al. Decreased Consumption of branched-chain amino acids improves metabolic health. Cell Rep. 16, 520–530 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Roth, G. A. et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1736–1788 (2018).

    Article  Google Scholar 

  39. Laslett, L. J. et al. The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College Of Cardiology. J. Am. Coll. Cardiol. 60, S1–S49 (2012).

    Article  PubMed  Google Scholar 

  40. Virani, S. S. et al. Heart disease and stroke statistics—2020 update: a report from the American Heart Association. Circulation 141, e139–e596 (2020).

    Article  PubMed  Google Scholar 

  41. Green, C. L. & Lamming, D. W. Regulation of metabolic health by essential dietary amino acids. Mech. Ageing Dev. 177, 186–200 (2019).

    Article  CAS  PubMed  Google Scholar 

  42. McGarrah, R. W. & White, P. J. Branched-chain amino acids in cardiovascular disease. Nat. Rev. Cardiol. 20, 77–89 (2023).

    Article  CAS  PubMed  Google Scholar 

  43. White, P. J. et al. Insulin action, type 2 diabetes, and branched-chain amino acids: a two-way street. Mol. Metab. 52, 101261 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Yu, D. et al. The adverse metabolic effects of branched-chain amino acids are mediated by isoleucine and valine. Cell Metab. 33, 905–922 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Deelen, J. et al. A metabolic profile of all-cause mortality risk identified in an observational study of 44,168 individuals. Nat. Commun. 10, 1–8 (2019).

    Article  ADS  Google Scholar 

  46. Yoon, M. S. mTOR as a key regulator in maintaining skeletal muscle mass. Front. Physiol. 8, 1–9 (2017).

    Article  MathSciNet  CAS  Google Scholar 

  47. Layman, D. K. et al. Defining meal requirements for protein to optimize metabolic roles of amino acids. Am. J. Clin. Nutr. 101, 1330S–1338S (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Churchward-Venne, T. A. et al. Supplementation of a suboptimal protein dose with leucine or essential amino acids: effects on myofibrillar protein synthesis at rest and following resistance exercise in men. J. Physiol. 590, 2751–2765 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Smith, G. I. et al. Protein ingestion induces muscle insulin resistance independent of leucine-mediated mTOR activation. Diabetes 64, 1555–1563 (2015).

    Article  CAS  PubMed  Google Scholar 

  50. Mittendorfer, B., Klein, S. & Fontana, L. A word of caution against excessive protein intake. Nat. Rev. Endocrinol. 16, 59–66 (2020).

    Article  PubMed  Google Scholar 

  51. Paddon-Jones, D., Sheffield-Moore, M., Katsanos, C. S., Zhang, X.J. & Wolfe, R. R. Differential stimulation of muscle protein synthesis in elderly humans following isocaloric ingestion of amino acids or whey protein. Exp. Gerontol. 41, 215–219 (2006).

    Article  CAS  PubMed  Google Scholar 

  52. Deutz, N. E. P. et al. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. Clin. Nutr. 33, 929–936 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Drummen, M., Tischmann, L., Gatta-Cherifi, B., Adam, T. & Westerterp-Plantenga, M. Dietary protein and energy balance in relation to obesity and co-morbidities. Front. Endocrinol. 9, 1–13 (2018).

    Article  Google Scholar 

  54. Magkos, F. The role of dietary protein in obesity. Rev. Endocr. Metab. Disord. 21, 329–340 (2020).

    Article  CAS  PubMed  Google Scholar 

  55. Huang, J. et al. Association between plant and animal protein intake and overall and cause-specific mortality. JAMA Intern. Med. 180, 1173–1184 (2020).

    Article  CAS  PubMed  Google Scholar 

  56. Green, C. L. et al. Sex and genetic background define the metabolic, physiologic, and molecular response to protein restriction. Cell Metab. 34, 209–226 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Condon, K. J. & Sabatini, D. M. Nutrient regulation of mTORC1 at a glance. J. Cell Sci. 132, 0–2 (2019).

    Article  CAS  Google Scholar 

  58. Bar-Peled, L. et al. A tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science 340, 1100–1106 (2013).

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  59. Wolfson, R. L. & Sabatini, D. M. The dawn of the age of amino acid sensors for the mTORC1 pathway. Cell Metab. 26, 301–309 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Han, J. M. et al. Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway. Cell 149, 410–424 (2012).

    Article  CAS  PubMed  Google Scholar 

  61. Wyant, G. A. et al. mTORC1 activator SLC38A9 is required to efflux essential amino acids from lysosomes and use protein as a nutrient. Cell 171, 642–654 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Son, S. M. et al. Leucine signals to mTORC1 via its metabolite acetyl-Coenzyme A. Cell Metab. 29, 192–201 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Yoshida, S., Pacitto, R., Yao, Y., Inoki, K. & Swanson, J. A. Growth factor signaling to mTORC1 by amino acid-laden macropinosomes. J. Cell Biol. 211, 159–172 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Doodnauth, S. A., Grinstein, S. & Maxson, M. E. Constitutive and stimulated macropinocytosis in macrophages: roles in immunity and in the pathogenesis of atherosclerosis. Philos. Trans. R Soc. B Biol. Sci. 374, 20180147 (2019).

    Article  CAS  Google Scholar 

  65. Lynch, C. J., Fox, H. L., Vary, T. C., Jefferson, L. S. & Kimball, S. R. Regulation of amino acid-sensitive TOR signaling by leucine analogues in adipocytes. J. Cell. Biochem. 77, 234–251 (2000).

    Article  CAS  PubMed  Google Scholar 

  66. Treviño-Villarreal, J. H. et al. Dietary protein restriction reduces circulating VLDL triglyceride levels via CREBH-APOA5-dependent and -independent mechanisms. JCI Insight. 3, e99470 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  67. Maida, A. et al. Dietary protein dilution limits dyslipidemia in obesity through FGF21-driven fatty acid clearance. J. Nutr. Biochem. 57, 189–196 (2018).

    Article  CAS  PubMed  Google Scholar 

  68. Smith, G. I. et al. High-protein intake during weight loss therapy eliminates the weight-loss-induced improvement in insulin action in obese postmenopausal women. Cell Rep. 17, 849–861 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. van Vliet, S. et al. The muscle anabolic effect of protein ingestion during a hyperinsulinaemic euglycaemic clamp in middle-aged women is not caused by leucine alone. J. Physiol. 596, 4681–4692 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  70. Dietzen, D. J. et al. Rapid comprehensive amino acid analysis by liquid chromatography/tandem mass spectrometry: comparison to cation exchange with post-column ninhydrin detection. Rapid Commun. Mass Spectrom. 22, 3481–3488 (2008).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank T. Roediger, the staff of the Center for Human Nutrition at Washington University School of Medicine and staff at the CTRU for assistance in conducting the metabolic studies and their technical assistance in processing the study samples. We also thank the study participants for their participation. Funding. This work was supported by National Institutes of Health grants R01 HL125838 (to B.R.), R01 HL159461 (to B.R. and B.M.), R01 DK121560 (to B.M.), R01 DK131188 (to B.R., B.M. and J.D.S.), P30 DK056341 (Washington University Nutrition and Obesity Research Center), P30 DK020579 (Washington University Diabetes Research Center), UL1 TR000448 (Washington University School of Medicine Institute of Clinical and Translational Sciences) and T32 HL134635 (to A.R.) and grants from the US Department of Veterans Affairs MERIT I01 BX003415 (to B.R.), American Diabetes Association (1-18-IBS-029 to B.R.) and the Longer Life Foundation (to B.M.). The funding sources had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review or approval of the manuscript; and decision to submit the manuscript for publication.

Author information

Author notes

  1. These authors contributed equally: Xiangyu Zhang, Divya Kapoor.

Authors and Affiliations

  1. Department of Medicine and Vascular Medicine Institute, University of Pittsburgh School of Medicine and UPMC, Pittsburgh, PA, USA

    Xiangyu Zhang, Yu-Sheng Yeh & Babak Razani

  2. Pittsburgh VA Medical Center, Pittsburgh, PA, USA

    Xiangyu Zhang, Yu-Sheng Yeh & Babak Razani

  3. Cardiovascular Division, Washington University School of Medicine, St Louis, MO, USA

    Divya Kapoor, Se-Jin Jeong, Ismail Sergin, Eman Yousif, Astrid Rodriguez-Velez, Arick Park, Joel D. Schilling, Abhinav Diwan, Nathan O. Stitziel & Ali Javaheri

  4. John Cochran VA Medical Center, St Louis, MO, USA

    Divya Kapoor, Abhinav Diwan & Ali Javaheri

  5. Division of Nutritional Science and Obesity Medicine, Washington University School of Medicine, St. Louis, MO, USA

    Alan Fappi, Vasavi Shabrish & Bettina Mittendorfer

  6. Departments of Medicine and Nutrition and Exercise Physiology, University of Missouri, Columbia, MO, USA

    Alan Fappi, Vasavi Shabrish & Bettina Mittendorfer

  7. Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St Louis, MO, USA

    Jeremiah Stitham & Irfan J. Lodhi

  8. Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, Shreveport, LA, USA

    Arif Yurdagul Jr & Oren Rom

  9. Peter Munk Cardiac Center and University Health Network, University of Toronto, Toronto, Canada

    Slava Epelman

  10. Department of Pediatrics, Washington University School of Medicine, St Louis, MO, USA

    Marco Sardiello

  11. Division of Hematology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA

    Jaehyung Cho

  12. Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA

    Jaehyung Cho

Authors
  1. Xiangyu Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Divya Kapoor
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Se-Jin Jeong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alan Fappi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jeremiah Stitham
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Vasavi Shabrish
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ismail Sergin
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Eman Yousif
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Astrid Rodriguez-Velez
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yu-Sheng Yeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Arick Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Arif Yurdagul Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Oren Rom
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Slava Epelman
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Joel D. Schilling
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Marco Sardiello
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Abhinav Diwan
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Jaehyung Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Nathan O. Stitziel
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Ali Javaheri
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. Irfan J. Lodhi
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. Bettina Mittendorfer
    View author publications

    You can also search for this author in PubMed Google Scholar

  23. Babak Razani
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

X.Z., D.K., B.M. and B.R. designed the study. X.Z., D.K., S.J.J., A.F., J.S., V.S., I.S., E.Y., A.R., Y.S.Y., A.P., A.Y., O.R., S.E., J.D.S., M.S., A.D., J.C., N.O.S., A.J., I.J.L., B.M. and B.R. contributed to data acquisition, data analysis and data interpretation. All authors contributed to the writing of the paper. B.R. is the guarantor of this work, had full access to all the data in the study and assumes full responsibility for the integrity of the data and the accuracy of the data analysis.

Corresponding authors

Correspondence to Bettina Mittendorfer or Babak Razani.

Ethics declarations

Competing interests

The authors declare no competing interests.

Peer review

Peer review information

Nature Metabolism thanks Andreas Pfeiffer and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Primary Handling Editor: Ashley Castellanos-Jankiewicz, in collaboration with the Nature Metabolism team.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Extended data

Extended Data Fig. 1 -for Main Fig. 1&2.

Extended Data Fig. 1 (A) Study #1 evaluated the effect of consuming extremes of protein intake as liquid meals (10% kcal protein vs 50% kcal protein) on monocyte mTORC1 activation and downstream functional events. Study #2 focused on a “real-world” setting and evaluated the effects of a standard mixed meal and a high-protein mixed meal (15% kcal vs 22% kcal as protein) on the same outcomes. Blood samples from participants were obtained at baseline and at defined time intervals after meal consumption, plasma was isolated for evaluating amino acid mass concentration and CD14 + /CD16− monocytes were isolated for mTORC1 signalling evaluation using Western blotting (WB), immunofluorescence microscopy (IF) and fluorescence-activated cell sorting (FACS). (B) Representative FACS pictures showing high efficiency of circulating monocytes isolation from participants’ blood. (C) Plasma triglyceride (TG) concentration before and after participants (n = 12) consumed a very high protein (50% kcal) or a low-protein (10% kcal) liquid meal (time as indicated). (D) Representative FACS pictures for Fig. 2d. (E) Quantification of mTOR-LAMP2 colocalization in isolated circulating monocytes participants (n = 5) consumed a very high protein (50% kcal) or a low-protein (10% kcal) liquid meals (time as indicated). P < 10e-8 and determined by Two-way ANOVA with Sidak’s multiple comparisons. Representative pictures on the right. (F) Plasma TG concentration before and after participants (n = 9) consumed a standard mixed meal (15% kcal protein) or a high protein (22% kcal protein) mixed meal (time as indicated). For all graphs, data are presented as mean ± SEM. ***P < 0.001.

Extended Data Fig. 2 -for Main Fig. 1.

Extended Data Fig. 2 Plasma concentrations of 20 amino acids before and after participants (n = 12) consumed a very high protein (50% kcal) or a low-protein (10% kcal) liquid meal (time as indicated). For all graphs, data are presented as mean ± SEM.

Extended Data Fig. 3 -for Main Fig. 2.

Extended Data Fig. 3 Plasma concentrations of 20 amino acids before and after participants (n = 9) consumed a standard mixed meal (15% kcal protein) or a high protein (22% kcal protein) mixed meal (time as indicated). For all graphs, data are presented as mean ± SEM.

Extended Data Fig. 4 -for Main Fig. 4.

Extended Data Fig. 4 (A) Representative images of cultured human monocytes-derived macrophages (HMDMs) from isolated human circulating monocytes before and after 12 days of differentiation. The picture represents for three independent experiments. (B-C) FACS (B) and immunofluorescence (C) analysis of differentiated HMDMs by macrophage markers CD11b, CD18 and CD68. The picture represents for three independent experiments. (D) Western blot analysis of mTOR activation in HMDM (using phospho-S6 and –S6K) after treatment with leucine (2 mM) or full amino acids. The picture represents for three independent experiments. (E-F) Immunofluorescence microscopy analysis and quantification of mTORC1 activation (using phospho-S6) (E) and autophagy inhibition (using LC3 puncta formation) (F) in HMDMs treated with 2 mM leucine. The IF data (E and F) were obtained from three independent experiments with analysis of n ≥ 15 cells per experiment (n = 45 in Group –aa and n = 40 in Group Leu for E; n = 58 in Group –aa and n = 58 in Group Leu for F). P < 10e-8 for E and F. (G) Representative images of LC3 in HMDMs for Fig. 5d. (H) Immunoblot analysis of the phosphorylation of AMPK and ULK1 in HMDMs by the selected amino acids (applied at 2 mM). n = 4 independent experiments per group. P = 0.00132 and determined by One-way ANOVA with Dunnett’s multiple comparisons. (I) Representative images of LC3 in HMDMs for Fig. 5g. For all graphs, data are presented as mean ± SEM, **P < 0.01 and ***P < 0.001.

Source data

Extended Data Fig. 5 -for Main Fig. 5.

Extended Data Fig. 5-for Main Fig. 5. (A) Western blot analysis of the dose-dependent effect of leucine on mTORC1 activation (using phospho-S6K) in human monocyte-derived macrophages (HMDMs). The picture represents for three independent experiments. (B) Representative FACS plots for Fig. 5e.

Source data

Extended Data Fig. 6 −for Main Fig. 6.

Extended Data Fig. 6 (A) Plasma concentrations of 20 amino acids before and after male mice were gavaged with a solution that contained 1.6 g/kg protein or vehicle (times as indicated). n = 3 mice for each group. (B) FACS analysis of mTORC1 activation in blood monocytes (using phosphorylated S6) from female mice gavaged with the same protein solution compared with vehicle (times as indicated). n = 4 mice for each group. P = 0.00829 and determined by Two-way ANOVA with Sidak’s multiple comparisons. For all graphs, data are presented as mean ± SEM. **P < 0.01.

Extended Data Fig. 7 Main Figs. 7 and 8.

Extended Data Fig. 7-for (A) Body composition (fat and lean weights) of ApoE-/- mice fed Western diets with low-protein (LP WD), moderate-protein (MP-WD), or high protein (HP-WD) contents for 8 weeks. n = 5 mice for each group. P = 0.00057. (B-C) Serum cholesterol (B) and triglyceride (C) concentrations in ApoE-/- mice before and after placement on low, moderate, or high protein Western diets for 8 weeks. n = 5 mice for each group. (D-E) Serum cholesterol (D) and triglyceride (E) concentrations after ApoE-/- mice were fed six different diets with varying protein and leucine contents, including: 1) a moderate-protein Western Diet (MP-WD, n = 10), 2) a high-protein Western Diet (HP-WD, n = 7), 3) a MP-WD to which an amount of leucine, but no other amino acids, was added to match the leucine content of the HP-WD (MP-WD+Leu, n = 10), 4) a MP-WD to which amino acids were added to match the total amino acid content of the HP-WD (MP-WD + AA, n = 10), 5) a MP-WD to which amino acids, except for leucine, were added to match the content of all amino acids, except for leucine, of the HP-WD (MP-WD + AA (Normal Leu), n = 15) and 6) an isonitrogenous MP-WD + AA-Leu diet (MP-WD + AA (Normal Leu (IsoN), n = 15) which consisted of the MP-WD + AA-Leu diet with additional amino acids to match the total amino acid nitrogen content of the HP WD. (F-H) Plaque composition quantified by immunofluorescence (IF) microscopy of aortic root sections for (F) macrophages (MOMA-2), (G) apoptosis (TUNEL + ) and (H) necrotic core (MP-WD, n = 10; HP-WD, n = 7; MP-WD+Leu, n = 10; MP-WD + AA, n = 10; MP-WD + AA(Normal Leu), n = 15; isoMP-WD + AA, n = 15 biologically independent animals). P = 0.0159 for F and P = 0.000329, 0.02219 and 0.00417 for G. For all graphs, data are presented as mean ± SEM and determined by One-way ANOVA with Dunnett’s multiple comparisons. *P ≤ 0.05, **P < 0.01 and ***P < 0.001.

Extended Data Fig. 8 CONSORT diagram of participant enrolment in Trials.

(A,B) CONSORT diagram of participant enrolment in Trial NCT03946774 (A) and Trial NCT03994367 (B).

Extended Data Fig. 9 Gating strategies for FACS analysis.

Gating strategy for determination of parameters in human (A) and mouse circulating monocytes (B). (A) Dead cells and cell aggregates were removed in (a) and (b) to enrich single live cells. (c) Human leucocytes were selected using CD45. (d) Human circulating monocytes were enriched by CD11b and F4/80 gating and used for further analysis. (B) Dead cells and cell aggregates were removed in (a) and (b) to enrich single live cells. (c) Mouse leucocytes were selected using CD45. (d) Mouse circulating monocytes were enriched by CD11b and Ly-6c gating and used for further analysis.

Supplementary information

Supplementary Information

Supplementary Table 1, clinical study protocol 1-2, CONSORT checklist, Reporting on sex and gender.

Reporting Summary

Source data

Source Data Fig. 1

Unprocessed western blots.

Source Data Fig. 2

Unprocessed western blots.

Source Data Fig. 3

Unprocessed western blots.

Source Data Fig. 4

Unprocessed western blots.

Source Data Fig. 5

Unprocessed western blots.

Source Data Extended Data Fig. 4

Unprocessed western blots.

Source Data Extended Data Fig. 5

Unprocessed western blots.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, X., Kapoor, D., Jeong, SJ. et al. Identification of a leucine-mediated threshold effect governing macrophage mTOR signalling and cardiovascular risk. Nat Metab 6, 359–377 (2024). https://doi.org/10.1038/s42255-024-00984-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s42255-024-00984-2

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research